We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 61-80 of 800 results
  1. Diabetes mellitus und Fettlebererkrankungen

    Nonalcoholic fatty liver disease (NAFLD) is a common, but often underestimated comorbidity of diabetes mellitus. It may not only be a consequence of...

    Jörg Bojunga, Andreas Geier in Der Gastroenterologe
    Article 26 February 2021
  2. Schmerzhafte erythematöse Knoten am Unterschenkel

    Lisanne Hake, Katharina Drerup, ... Christian Drerup in Die Dermatologie
    Article 30 August 2021
  3. Hepatic manifestations of systemic disease: an imaging-based review

    The liver is responsible for many processes that maintain human metabolic homeostasis and can be affected by several pediatric systemic diseases. In...

    Joseph Y. Cao, Maddy Artunduaga, Gary R. Schooler in Pediatric Radiology
    Article 19 November 2021
  4. Hepatotoxicity in Adeno-Associated Viral Vector Gene Therapy

    Purpose of Review

    Recombinant adeno-associated virus (rAAV) is the commonest viral vector used in gene therapies. With the increase in the number of...

    Barath Jagadisan, Anil Dhawan in Current Hepatology Reports
    Article Open access 20 December 2023
  5. Medikamentöse Therapie der Adipositas – Konkurrenz zur bariatrischen Chirurgie oder sinnvolle Ergänzung?

    Obesity is a complex chronic disease and requires a long-term multimodal approach. The current treatment algorithm for treatment of obesity mainly...

    Tina Mazaheri, Saleem Ansari, ... Alexander Dimitri Miras in Die Chirurgie
    Article 14 March 2023
  6. Lebererkrankungen bei Diabetes mellitus – Fallberichte

    Liver diseases have been part of the everyday life of general practitioners and internists for decades. They are common in diabetes mellitus, but...

    Matthias Kaltheuner in Der Diabetologe
    Article 08 September 2020
  7. Systemische Auswirkungen und klinische Aspekte der SARS-CoV-2-Infektion

    Background

    COVID-19 is considered a systemic disease. A severe course with fatal outcome is possible and unpredictable.

    Objectives

    Which organ systems...

    Sigurd F. Lax, Kristijan Skok, ... Michael Trauner in Der Pathologe
    Article Open access 11 February 2021
  8. Aktuelle Studienergebnisse aus einem Jahr Forschung

    Peter Stiefelhagen in Gastro-News
    Article 28 August 2020
  9. Schwere sekundär sklerosierende Cholangitis als Manifestation einer sehr seltenen Grunderkrankung

    Langerhans cell histiocytosis (LCH) is a very rare cause of secondary sclerosing cholangitis. We report the case of a 42-year-old male patient with...

    Britta Franziska Zecher, Roman Zenouzi, ... Marcial Sebode in Der Internist
    Article 21 September 2021
  10. Progress im Management des cholangiozellulären Karzinoms

    Liver cancer, especially cholangiocarcinoma (CC), is a significant cause of cancer deaths in Austria. CC is divided into gallbladder and bile duct...

    Dajana Bolf, Katja Schmitz, Markus Peck-Radosavljevic in Journal für Gastroenterologische und Hepatologische Erkrankungen
    Article 26 January 2024
  11. Diagnostics of messenger ribonucleic acid (mRNA) severe acute respiratory syndrome-corona virus‑2 (SARS-CoV‑2) vaccination-associated myocarditis—A systematic review

    Background

    During the recent pandemic with the severe acute respiratory syndrome-corona virus‑2 the first messenger ribonucleic acid (mRNA) vaccines...

    Jan M. Federspiel, Frank Ramsthaler, ... Gerhard Mall in Rechtsmedizin
    Article 20 July 2022
  12. Diabetes mellitus, Zöliakie und weizenassoziierte Erkrankungen

    Autoimmune diseases such as celiac disease occur more frequently in people with type 1 diabetes than in metabolically healthy individuals. Overall,...

    Jörg Bojunga, Kerstin Jacobs, Daniel Pauli in Die Diabetologie
    Article 10 February 2023
  13. Portal venous and hepatic artery hemodynamic variation in non-alcoholic fatty liver disease

    Background

    Non-alcoholic fatty liver disease remains asymptomatic until advanced disease, when risk factor modification and available treatment become...

    Manal Sabry, Tarek Youssef, ... Christina Alfons Anwar in Egyptian Liver Journal
    Article Open access 30 June 2021
  14. Hoher Zucker, hohe Triglyzeride: nicht immer metabolisches Syndrom

    Winfried März, Gerald Klose in CardioVasc
    Article 14 December 2021
  15. Meningoenzephalitis und ophthalmologische Symptome

    A. Kraft, F. Hoffmann in DGNeurologie
    Article 24 March 2021
Did you find what you were looking for? Share feedback.